These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 19575874

  • 1. [Clinicopathologic features and prognostic significance of basal-like breast cancer].
    Liu H, Fan QH, Li X, Liu GZ.
    Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):316-22. PubMed ID: 19575874
    [Abstract] [Full Text] [Related]

  • 2. [Roles of immunohistochemistry in prognostic assessment of basal-like breast cancer].
    Liu H, Fan QH, Zhang ZH, Li X, Yu HP, Liu GZ, Meng FQ.
    Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):23-8. PubMed ID: 19489221
    [Abstract] [Full Text] [Related]

  • 3. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G.
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [Abstract] [Full Text] [Related]

  • 4. [Clinicopathologic features and immunohistochemistry of the basal-like subtype of invasive breast carcinoma].
    Liu LP, Bai J, Wei Y, Qi XD, Si TC, Li W, Pan H.
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):101-5. PubMed ID: 23710916
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
    Yu L, Yang WT, Cai X, Lu HF, Fan YZ, Shi DR.
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathologic features of breast carcinomas classified by biomarkers and correlation with microvessel density and VEGF expression: a study from Thailand.
    Chuangsuwanich T, Pongpruttipan T, O-Charoenrat P, Komoltri C, Watcharahirun S, Sa-Nguanraksa D.
    Asian Pac J Cancer Prev; 2014 Oct; 15(3):1187-92. PubMed ID: 24606439
    [Abstract] [Full Text] [Related]

  • 7. [Morphological features of basal-like subtype invasive carcinoma of breast].
    Gao LX, Yang GZ, Ding HY, Li L.
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):83-7. PubMed ID: 18681317
    [Abstract] [Full Text] [Related]

  • 8. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A, Sussman ZM, Lawson D, Cohen C.
    Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
    [Abstract] [Full Text] [Related]

  • 9. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y.
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [Abstract] [Full Text] [Related]

  • 10. Fibrotic focus in breast carcinomas: relationship with prognostic parameters and biomarkers.
    Mujtaba SS, Ni YB, Tsang JY, Chan SK, Yamaguchi R, Tanaka M, Tan PH, Tse GM.
    Ann Surg Oncol; 2013 Sep; 20(9):2842-9. PubMed ID: 23539156
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Ono M, Tsuda H, Yoshida M, Shimizu C, Kinoshita T, Tamura K.
    Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822
    [Abstract] [Full Text] [Related]

  • 18. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
    Sánchez-Muñoz A, Román-Jobacho A, Pérez-Villa L, Sánchez-Rovira P, Miramón J, Pérez D, Sáez MI, de Luque V, Medina L, Ramírez-Tortosa CL, Vicioso L, Medina JA, Ribelles N, Alba E.
    Oncology; 2012 Feb; 83(4):228-33. PubMed ID: 22907070
    [Abstract] [Full Text] [Related]

  • 19. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
    Cakir A, Isik Gonul I, Ekinci O, Cetin B, Benekli M, Uluoglu O.
    Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.